Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.12788/cutis.0959 | DOI Listing |
Cutis
February 2024
Drs. Barone and Fivenson are from the Department of Dermatology, Trinity Health Ann Arbor Hospital, Ypsilanti, Michigan. Dr. Schapiro is from CTA Pathology, Ann Arbor.
Arch Dermatol Res
September 2023
Department of Dermatology, Massachusetts General Hospital, , Harvard Medical School, 50 Staniford St, Boston, MA, 02114, USA.
Kaposi sarcoma (KS) is a low-grade vascular malignancy caused by human herpesvirus-8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV). There are four established subtypes of KS, which are described by unique risk factors, presentation, and disease course. A "non-epidemic" variant to describe HIV-negative men who have sex with men (MSM) is emerging as a fifth subtype.
View Article and Find Full Text PDFCancers (Basel)
December 2021
Service de Virologie, Hôpital Pitié-Salpêtrière, AP-HP, Institut Pierre Louis d'Épidémiologie et de Santé Publique (iPLESP), INSERM, Sorbonne Université, 75013 Paris, France.
Kaposi's sarcoma-associated herpesvirus (KSHV), also called human herpesvirus 8 (HHV-8), is an oncogenic virus belonging to the family. The viral particle is composed of a double-stranded DNA harboring 90 open reading frames, incorporated in an icosahedral capsid and enveloped. The viral cycle is divided in the following two states: a short lytic phase, and a latency phase that leads to a persistent infection in target cells and the expression of a small number of genes, including LANA-1, v-FLIP and v-cyclin.
View Article and Find Full Text PDFInt J STD AIDS
May 2020
STI Unit, Center for International Health and Communicable Diseases Drassanes-Vall d'Hebron, Hospital Vall d'Hebron, Barcelona, Spain.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!